分裂感情障害治療のグローバル臨床試験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Schizoaffective Disorder Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Schizoaffective Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Schizoaffective Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Schizoaffective Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Schizoaffective Disorder 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Schizoaffective Disorder Therapeutics Clinical Trials 31
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Johnson & Johnson 33
Clinical Trial Overview of Johnson & Johnson 33
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Eli Lilly and Company 39
Clinical Trial Overview of Eli Lilly and Company 39
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Bristol-Myers Squibb Company 42
Clinical Trial Overview of Bristol-Myers Squibb Company 42
Sumitomo Dainippon Pharma Co., Ltd. 43
Clinical Trial Overview of Sumitomo Dainippon Pharma Co., Ltd. 43
Otsuka Holdings Co., Ltd. 44
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 44
AbbVie Inc. 45
Clinical Trial Overview of AbbVie Inc. 45
North Shore-Long Island Jewish Health System, Inc. 46
Clinical Trial Overview of North Shore-Long Island Jewish Health System, Inc. 46
Merck & Co., Inc. 47
Clinical Trial Overview of Merck & Co., Inc. 47
Clinical Trial Overview of Top Institutes / Government 48
U.S. Department of Veterans Affairs 48
Clinical Trial Overview of U.S. Department of Veterans Affairs 48
University of Maryland 50
Clinical Trial Overview of University of Maryland 50
University of Pittsburgh 51
Clinical Trial Overview of University of Pittsburgh 51
Yale University 52
Clinical Trial Overview of Yale University 52
Centre for Addiction and Mental Health 53
Clinical Trial Overview of Centre for Addiction and Mental Health 53
National Institute of Mental Health 54
Clinical Trial Overview of National Institute of Mental Health 54
Vanderbilt University 55
Clinical Trial Overview of Vanderbilt University 55
Dartmouth-Hitchcock Medical Center 56
Clinical Trial Overview of Dartmouth-Hitchcock Medical Center 56
Massachusetts General Hospital 57
Clinical Trial Overview of Massachusetts General Hospital 57
North Suffolk Mental Health Association 58
Clinical Trial Overview of North Suffolk Mental Health Association 58
Five Key Clinical Profiles 59
Appendix 89
Abbreviations 89
Definitions 89
Research Methodology 90
Secondary Research 90
About GlobalData 91
Contact Us 91
Disclaimer 91
Source 91


【レポート販売概要】

■ タイトル:分裂感情障害治療のグローバル臨床試験動向(2014年下半期)
■ 英文:Schizoaffective Disorder Global Clinical Trials Review, H2, 2014
■ 発行日:2014年7月28日
■ 調査会社:GlobalData
■ 商品コード:GDHC2269CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。